Page 156 - YORAM RUDY BOOK FINAL
P. 156

P. 156
                   5.7   Arrhythmic Substrates of Hereditary Cardiac Disorders



        The Long QT (LQT) Syndrome        309



               The congenital LQT syndrome is an inherited cardiac channelopathy that can cause
        syncope and sudden death in young adults with structurally normal hearts . Arrhythmias in
                                                                                          310
        these patients are classified as polymorphic ventricular tachycardia (torsades de pointes).
        The genetic and molecular basis of LQT has been studied extensively         311,312 . However, the arrhythmic

        substrate in the hearts of LQT patients has not been fully defined. We have used ECGI to map the
        EP substrate in 25 patients with genotype-positive, phenotype-positive LQT syndrome            309 . Based
        on identified mutations there were nine LQT1 patients (loss-of-function mutations in KCNQ1,

        leading to reduced I ), nine LQT2 (loss-of-function mutations in KCNH2 and reduced I ), five LQT3
                                                                                                      Kr
                              Ks
        (gain-of-function mutations in SCN5A and increased I ) and two LQT5 (loss- of-function
                                                                   Na
        mutations in KCNE1 and reduced I ). Epicardial activation in sinus rhythm is normal in all LQT
                                              Ks
        types (Figure 5.19). RV epicardial breakthrough is in the normal location. Conduction is uniform
        without regions of slow conduction or conduction block, and latest activation is in the LV base.

        Total ventricular activation time (TVAT) is around 50 ms, within the normal range. In marked
        contrast to activation, repolarization in LQT of all types is very abnormal (Figure 5.20), with
        prolongation of the action potential (measured by ARI) on the ventricular epicardium compared

        with normal control. The prolongation is spatially heterogeneous, introducing regions of steep
        dispersion of repolarization. Figure 5.20 shows representative ARI maps for control (left column)
        and (from left to right, starting from second column) LQT1, LQT2, and LQT3 in anterior and inferior





























        Figure 5.19. Epicardial activation isochrones maps. Examples of activation in (left to right)
        control, LQT1, LQT2, and LQT3. In all LQT types as in normal control, epicardial activation starts
        from breakthrough at anterior RV (asterisk) 20 ms to 30 ms after QRS onset. It proceeds in a
        uniform fashion to activate the ventricles synchronously. The latest region to activate is the LV
        basal region. The total ventricular activation time (TVAT) in all LQT types is ~ 50 ms, comparable
        with normal control. AO indicates the aorta. From Vijayakumar et. al. [309] with permission of
        Wolters Kluwer Health, Inc.
   151   152   153   154   155   156   157   158   159   160   161